Revvity, Inc. (RVTY) Yield on Cost (YOC): 0.29%
The yield on cost (YOC) for Revvity, Inc. (RVTY) is 0.29%.
RVTY Yield on Cost (YOC) Metrics
YIELD ON COST (YOC)
0.29%
Yield on Cost for RVTY
RVTY now pays $0.28 per share a year. Measured against the price it actually traded at back then, a long-term holder is earning:
| If you bought | Price then | Yield on cost today |
|---|---|---|
| 10 years ago(2016-06-14) | $53.25 | 0.53% |
| 5 years ago(2021-06-22) | $153.20 | 0.18% |
| 3 years ago(2023-06-12) | $113.50 | 0.25% |
| 1 year ago(2025-06-16) | $96.35 | 0.29% |
| Buying today(at $97.82) | $97.82 | 0.29% |
If you buy today and the dividend keeps growing
Projection: starting from today's 0.29% yield, assuming the dividend keeps compounding at its historical 0.0% rate. Boards set dividends each year, so actual figures will differ.
Today
0.29%
In 3 years
0.29%
In 5 years
0.29%
In 10 years
0.29%
Yield on Cost Calculator
Try your own purchase price, dividend and growth rate for Revvity, Inc. (RVTY).
Starting Yield
0.29%
Ending YOC
0.74%
Year 15 Dividend
$0.72
Cum. Dividends Recd.
$7.21
| Year | Projected Div. / Share | YoY Dividend Hike | Yield on Cost (YOC) | Total Dividends Recd. |
|---|---|---|---|---|
| Initial | $0.28 | — | 0.29% | $0.00 |
| Year 1 | $0.30 | +6.50% | 0.30% | $0.30 |
| Year 2 | $0.32 | +6.50% | 0.32% | $0.62 |
| Year 3 | $0.34 | +6.50% | 0.35% | $0.95 |
| Year 4 | $0.36 | +6.50% | 0.37% | $1.31 |
| Year 5 | $0.38 | +6.50% | 0.39% | $1.70 |
| Year 6 | $0.41 | +6.50% | 0.42% | $2.11 |
| Year 7 | $0.44 | +6.50% | 0.44% | $2.54 |
| Year 8 | $0.46 | +6.50% | 0.47% | $3.00 |
| Year 9 | $0.49 | +6.50% | 0.50% | $3.50 |
| Year 10 | $0.53 | +6.50% | 0.54% | $4.02 |
| Year 11 | $0.56 | +6.50% | 0.57% | $4.58 |
| Year 12 | $0.60 | +6.50% | 0.61% | $5.18 |
| Year 13 | $0.63 | +6.50% | 0.65% | $5.81 |
| Year 14 | $0.68 | +6.50% | 0.69% | $6.49 |
| Year 15 | $0.72 | +6.50% | 0.74% | $7.21 |
Revvity, Inc. Yield on Cost (YOC) Formula & Definition
Yield on cost is the dividend yield measured against your original purchase price, not today's price. As a company raises its dividend, the yield on what you actually paid keeps rising even when the market yield holds steady.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Revvity, Inc. Yield on Cost (YOC) FAQ
- What is the yield on cost (YOC) for Revvity, Inc. (RVTY)?
- The yield on cost (YOC) for RVTY stock is 0.29%.
About Revvity, Inc.
Revvity, Inc., founded in 1937 and based in Waltham, Massachusetts, is a global enterprise that develops and delivers a wide array of products, services, and solutions. The company, which changed its name from PerkinElmer, Inc. in April 2023, caters to the diagnostics, life sciences, and applied services sectors worldwide. Its Discovery & Analytical Solutions division provides advanced instrumentation, reagents, informatics, software, subscriptions, and sophisticated detection and imaging technologies. These resources are designed to enable scientists to achieve significant breakthroughs in life sciences research. This segment also offers contract research and specialized laboratory services. Furthermore, it supplies analytical tools and services for assessing environmental health, including air, water, and soil, and delivers solutions to agricultural and food producers. It also serves the industrial market with analytical instrumentation for sectors such as chemical, semiconductor, electronics, energy, lubricants, petrochemicals, and polymers. The Diagnostics segment is dedicated to early detection, offering instruments, reagents, assay platforms, and software for identifying genetic disorders in pregnant individuals and young children, alongside infectious disease testing. Its products facilitate the screening of genetic abnormalities, disorders, and diseases like Down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This division also innovates technologies that support genomic workflows, leveraging protein-coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. Revvity serves a diverse clientele, including pharmaceutical and biotechnology firms, laboratories, academic and research institutions, public health authorities, private healthcare organizations, medical professionals, and government bodies.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Prahlad R. Singh